Humaid Al-Shamsi, CEO of Burjeel Cancer Institute and Chairman of Nexomic, shared on X:
“Praise be to God, I published 5 new studies last week in the world’s leading cancer-specialized scientific journals, bringing the total to 45 peer-reviewed scientific papers for the year 2026, making it the most productive year in my scientific and academic career, praise be to God.
The highlights among the studies involve using a modern technique via detection of DNA remnants to identify the risk of colon cancer recurrence after recovery from it.
The study was conducted with my colleagues at Houston Methodist Hospital MethodistHosp in the United States and Saint Joseph University in Beirut, Lebanon USJLiban.
We look forward to more scientific research to develop a global cancer treatment system, God willing.”
Other articles from Humaid Al-Shamsi on OncoDaily.